Cargando…
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
BACKGROUND: Peripheral artery disease (PAD) is recognized as a significant predictor of mortality and adverse cardiovascular outcomes in patients with coronary heart disease (CHD). In fact, coexisting PAD and CHD is strongly associated with a greater coronary event recurrence compared with either on...
Autores principales: | Yubero-Serrano, Elena M., Alcalá-Diaz, Juan F., Gutierrez-Mariscal, Francisco M., Arenas-de Larriva, Antonio P., Peña-Orihuela, Patricia J., Blanco-Rojo, Ruth, Martinez-Botas, Javier, Torres-Peña, Jose D., Perez-Martinez, Pablo, Ordovas, Jose M., Delgado-Lista, Javier, Gómez-Coronado, Diego, Lopez-Miranda, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993540/ https://www.ncbi.nlm.nih.gov/pubmed/33766036 http://dx.doi.org/10.1186/s12933-021-01260-3 |
Ejemplares similares
-
Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021) -
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
por: Blanco-Rojo, Ruth, et al.
Publicado: (2017) -
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023) -
Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study
por: de la Cruz-Ares, Silvia, et al.
Publicado: (2021) -
Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
por: Yubero-Serrano, Elena M., et al.
Publicado: (2020)